Inmune Bio Inc (INMB)

Jun 11, 2026

INMB Q4 2025 Earnings: EPS Surprise of 24.6% Highlights Operational ProgressNon-GAAP Earnings - newsline.com

Jun 11, 2026

Jun 08, 2026

INMB Q4 2025 Earnings: EPS Beat Surprises Street as Clinical Pipeline AdvancesTax Rate Impact - newsline.com

Jun 08, 2026

Jun 02, 2026

INmune Bio reports positive Phase 2 MRI results - TipRanks

Jun 02, 2026

Jun 02, 2026

New MRI biomarker backs INmune Bio (NASDAQ: INMB) Alzheimer’s drug - Stock Titan

Jun 02, 2026

Jun 02, 2026

INMB: INmune Bio Reports Promising MRI Findings from Alzheimer's Trial - GuruFocus

Jun 02, 2026

Jun 02, 2026

INmune Bio Reports Statistically Significant Treatment Effect On Advanced White Matter MRI Biomarker In Phase 2 MINDFuL Alzheimer's Trial - marketscreener.com

Jun 02, 2026

Jun 02, 2026

INmune Bio reports positive MRI results from Alzheimer’s trial - Investing.com

Jun 02, 2026

Jun 02, 2026

INmune Bio Reports Statistically Significant Treatment Effect On Advanced White Matter MRI Biomarker In Phase 2 Mindful Alzheimer's Trial - TradingView

Jun 02, 2026

Jun 02, 2026

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial - The Manila Times

Jun 02, 2026

Jun 02, 2026

Brain scans in early Alzheimer’s trial show drug affecting white matter - Stock Titan

Jun 02, 2026

Jun 02, 2026

INMB Q4 2025 Earnings: Narrowed Loss Per Share Exceeds Expectations Amidst Pipeline ProgressEarnings Revision Upgrade - newsline.com

Jun 02, 2026

Jun 01, 2026

INmune Bio (INMB) Q4 2025 Earnings Transcript - The Globe and Mail

Jun 01, 2026

Jun 01, 2026

INmune Bio Inc. (INMB) Navigates Near Support Levels Amid Modest DeclineValue Stock Ideas - newsline.com

Jun 01, 2026

May 31, 2026

INmune Bio (INMB) Holds Near Support Amid Modest Decline – Key Levels in FocusAAII Bearish - newsline.com

May 31, 2026

May 29, 2026

Inmune Bio Inc stock (US45764T1060): Short interest rose in May - AD HOC NEWS

May 29, 2026

May 28, 2026

INMB Q4 2025 Earnings: EPS Beat Surprises as Clinical-Stage Biotech Advances PipelineConsensus Miss Rate - The Legal Advocate

May 28, 2026

May 27, 2026

INmune Bio Inc. (INMB) Slips Further as Stock Tests Key Support at $1.35BPI Reversal - The Legal Advocate

May 27, 2026

May 25, 2026

INmune Bio Inc. (INMB) Holds Near Support as Biotech Stock Edges HigherTake Profit Levels - newsline.com

May 25, 2026

May 23, 2026

INMB Q4 2025 Earnings: Narrower Loss Beats Estimates, Pipeline Progress HighlightedWeak Earnings Momentum - The Legal Advocate

May 23, 2026

May 22, 2026

INMB Q4 2025 Earnings: EPS Surpasses Estimates as Loss NarrowsEarnings Stability Report - thelegaladvocate.com

May 22, 2026

May 22, 2026

INMB Q4 2025 Earnings: Narrowing Losses Amid Clinical Pipeline ProgressInterim Report - newsline.com

May 22, 2026

May 21, 2026

Inmune Bio Inc stock (US45764T1060): eyes on upcoming 2025 results and Alzheimer’s pipeline - AD HOC NEWS

May 21, 2026

May 20, 2026

INMB Stock Price, Quote & Chart | INMUNE BIO INC (NASDAQ:INMB) - ChartMill

May 20, 2026

May 19, 2026

INmune Bio (INMB) Crushes Q4 2025 Estimates — EPS $-0.20 Tops ViewsBanking Earnings Report - The Legal Advocate

May 19, 2026

May 18, 2026

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro Platform - marketscreener.com

May 18, 2026

May 17, 2026

Inmune Bio stock (US45764T1060): Year-end 2025 results and update in focus - AD HOC NEWS

May 17, 2026

May 15, 2026

INmune Bio publishes Alzheimer’s trial results in journal - Investing.com UK

May 15, 2026

May 15, 2026

INMB Shows Promising Alzheimer's Results in MINDFuL Trial - GuruFocus

May 15, 2026

May 15, 2026

INmune Bio: Interview With Co-Founder & CEO David Moss About The Immunotherapies Company - Pulse 2.0

May 15, 2026

May 15, 2026

INmune Bio publishes Alzheimer’s trial results in journal By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform - The Manila Times

May 15, 2026

May 15, 2026

Alzheimer’s drug XPro shows directionally consistent benefits, no ARIA - Stock Titan

May 15, 2026

May 14, 2026

INmune Bio Receives FDA Fast Track for XPro - TipRanks

May 14, 2026

May 14, 2026

INMB Secures Fast Track Designation for Alzheimer's Treatment - GuruFocus

May 14, 2026

May 14, 2026

INmune Bio (NASDAQ: INMB) wins FDA Fast Track status for XPro in early Alzheimer’s disease - Stock Titan

May 14, 2026

May 14, 2026

INmune Bio receives FDA fast track status for Alzheimer’s drug - Investing.com UK

May 14, 2026

May 14, 2026

INmune Bio (INMB) Stock: Up +14.73%, Key Resistance at $1.76 2026-05-14Expert Entry Points - newser.com

May 14, 2026

May 14, 2026

INmune Bio's XPro1595 gets FDA Fast Track for early Alzheimer's treatment - Pluang

May 14, 2026

May 14, 2026

INmune Bio stock surges on FDA Fast Track for Alzheimer’s drug By Investing.com - Investing.com South Africa

May 14, 2026

May 14, 2026

INmune Bio stock surges on FDA Fast Track for Alzheimer’s drug - Investing.com Australia

May 14, 2026

May 14, 2026

INmune Bio receives FDA fast track designation for XPro1595 in early Alzheimer's disease - marketscreener.com

May 14, 2026

May 14, 2026

INmune Bio receives FDA fast track status for Alzheimer’s drug By Investing.com - Investing.com Australia

May 14, 2026

May 14, 2026

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease - The Manila Times

May 14, 2026

May 14, 2026

FDA Fast Tracks brain-inflammation drug for early Alzheimer’s - Stock Titan

May 14, 2026

May 13, 2026

INmune Bio (INMB) Q1 2026 Earnings Transcript - AOL.com

May 13, 2026

May 13, 2026

INmune Bio joins 26 companies to form American Biotech Innovation Alliance for US biotech leadership - Pluang

May 13, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 09, 2026

INmune Bio, Inc. (NASDAQ:INMB) Q1 2026 Earnings Call Transcript - Insider Monkey

May 09, 2026

May 09, 2026

INMB: INmune BioInteractive Chart - Zacks Investment Research

May 09, 2026

May 08, 2026

Expanding partnership aims to advance stem cell therapy to treat RDEB - Epidermolysis Bullosa News

May 08, 2026

May 08, 2026

Q1 2026 INmune Bio Inc Earnings Call Transcript - GuruFocus

May 08, 2026